Subscribe to our Newsletters !!

    cancer

    Jellagen dispatches JellaGel™, the principal Collagen Type 0 Hydrogel taking available driving Extracellular Matrix

    Jellagen® Limited, a biotechnology company manufacturing high-value Collagen Type 0 derived from jellyfish, announce the launch of their JellaGel™ Hydrogel. 3-dimensaional Hydrogels make it possible for cells to grow and interact with all of their surroundings that makes a massive difference. Cells grown in a 3D model have been shown to be more natural, with

    Recently recognized supplement helps the gut review earlier diseases and execute attacking bacteria

    Scientists studying the body’s natural defenses against bacterial disease have identified a nutritional supplement –taurine–that helps the gut recall prior infections and kill invading bacteria, such as Klebsiella pneumoniae (Kpn). The finding, published in the journal Cell by scientists from five institutes of the National Institutes of Health, could help efforts seeking alternatives to antibiotics.

    Inflammation may add to the determination of C. diff disease, shows study

    A new study from North Carolina State University indicates that the inflammation brought on by Clostridioides difficile (C. diff) infection gives the pathogen a two-fold advantage: by both creating an inhospitable environment for competing bacteria and supplying nutrients that enable C. diff to thrive. C. diff is a bacterium that causes diarrhea, often with severe

    Daily aspirin can lessen danger of colorectal disease in adults

    Regular aspirin use has clear benefits in reducing colorectal cancer incidence among middle-aged adults, but also comes with some risk, such as gastrointestinal bleeding. And when should adults start taking regular aspirin and for how long? There is substantial evidence that a daily aspirin can reduce risk of colorectal cancer in adults up to age

    New upkeep treatment for AML shows solid advantage for patients

    Patients with acute myeloid leukemia (AML), the most common form of leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance therapy, based on a randomized, international phase 3 clinical

    Corning to feature most current product in 3D cell culture portfolio at SLAS2021

    Corning Incorporated will highlight its hottest technologies that support the advancement of 3D cell culture, automation, and drug discovery in this year’s virtual Society for Laboratory Automation and Screening (SLAS) seminar on Jan. 25 through 27. Now more than ever, tools used to ease scale-up, reproducibility, and consistency of 3D cell culture are helping empower

    World’s first completely reversible control of the circadian clock

    The Nagoya University Institute of Transformative Bio-Molecules (WPI-ITbM) research team of Designated Associate Professor Tsuyoshi Hirota, Postdoctoral Fellow Simon Miller, Professor Kenichiro Itami and grad student Tsuyoshi Oshima (Research Fellowship for Young Scientists, JSPS), in collaboration with the team of Professor Ben Feringa and Postdoctoral Fellow Dušan Kolarski of Groningen University in the Netherlands, have

    UNSW builds up a clay based ink to 3D-print bone parts with living cells

    3D printers may one day become a permanent fixture of the operating theatre after UNSW scientists showed they could print bone-like structures comprising living cells. Researchers from UNSW Sydney have developed a ceramic-based ink which may allow surgeons in the long run to 3D-print bone elements complete with living cells which could be used to